Oncological Outcomes of Radical Prostatectomy versus Radiotherapy in Solid Organ Transplant Recipients with Prostate Cancer: A Single-Center Retrospective Study
Prostate International · 2026-10
DOI: 10.1016/j.prnil.2026.10.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostate International, 2026-10. Verfasst von Younjuong Kim und 8 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Introduction
Whether radical prostatectomy (RP) or radiotherapy (RTx) yields better prostate cancer (PCa) outcomes in solid organ transplant (SOT) recipients remains unclear. We compared RP and RTx outcomes in SOT recipients with non-metastatic post-transplant PCa, with further investigation into differences across transplanted organ types. Materials and Methods In a single center, we retrospectively analyzed 35 RP patients and 32 RTx patients diagnosed with non-metastatic PCa after SOT. Transplant organs included kidney (n = 21), liver (n = 40), heart (n = 3), and lung (n = 3). Biochemical recurrence-free survival (BCRFS) and overall survival (OS) were compared using Kaplan–Meier analysis and Cox proportional hazards regression.
Results
Over a median follow-up of 48.6 months, BCR occurred in 7 (10.4%) patients and 10 (14.9%) patients died. There was no significant difference in BCRFS between RP and RTx (log-rank p = 0.322; adjusted HR 1.53, 95% CI 0.29–8.10, p = 0.62). On univariate analysis, RTx was associated with worse OS (HR 6.75, 95% CI 1.39–32.69, p = 0.018); however, this association did not persist after adjusting for transplant organ type (adjusted HR 3.66, 95% CI 0.65–20.62, p = 0.14). Heart/lung transplantation remained independently associated with worse OS after adjusting for treatment modality (adjusted HR 6.04, 95% CI 1.22–29.85, p = 0.03).
Conclusion
No statistically significant difference in oncological outcomes between RP and RTx was detected in this small cohort, although the wide confidence intervals of the adjusted estimates cannot exclude a clinically meaningful treatment difference. Transplant organ type (heart/lung vs. kidney/liver) remained significantly associated with OS after adjustment for treatment modality.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, Y., Kim, Y. J., Kim, Y. S., Lim, B., Kim, J. K., You, D., Jeong, I. G., Hong, J. H., & Suh, J. (2026). Oncological Outcomes of Radical Prostatectomy versus Radiotherapy in Solid Organ Transplant Recipients with Prostate Cancer: A Single-Center Retrospective Study. Prostate International. https://doi.org/10.1016/j.prnil.2026.10.002
Vancouver
Kim Y, Kim YJ, Kim YS, Lim B, Kim JK, You D, et al. Oncological Outcomes of Radical Prostatectomy versus Radiotherapy in Solid Organ Transplant Recipients with Prostate Cancer: A Single-Center Retrospective Study. Prostate International. 2026. doi:10.1016/j.prnil.2026.10.002
BibTeX
@article{Kim2026,
author = {Kim, Younjuong and Kim, Yeon Joo and Kim, Young Seok and Lim, Bumjin and Kim, Jung Kwon and You, Dalsan and Jeong, In Gab and Hong, Jun Hyuk and Suh, Jungyo},
title = {Oncological Outcomes of Radical Prostatectomy versus Radiotherapy in Solid Organ Transplant Recipients with Prostate Cancer: A Single-Center Retrospective Study},
journal = {Prostate International},
year = {2026},
doi = {10.1016/j.prnil.2026.10.002}
}
EUVIMED